Details of Drug

Drug General Information (ID: D0713)
Drug Name	Gefitinib
Drug Type	Small molecule
Drug Synonymous	Gefitini; IRE; Iressa; Irressat; Gefitinib [USAN]; ZD 1839; ZD1839; Iressa (TN); Iressa(TM); ZD-1839; CU-00000000396-1; Gefitinib,Iressa, ZD1839; Gefitinib (JAN/USAN/INN); ZD-1839, Iressa, Gefitinib; N-(3-Chloro-4-fluorophenyl)-7-methoxy-6-(3-morpholinopropoxy)quinazolin-4-amine; N-(3-chloro-4-fluorophenyl)-7-methoxy-6-(3-(4-morpholinyl)propoxy)-4-quinazolinamide; N-(3-chloro-4-fluorophenyl)-7-methoxy-6-(3-morpholin-4-ylpropoxy)quinazolin-4-amine; N-(3-chloro-4-fluorophenyl)-7-methoxy-6-[3-(morpholin-4-yl)propoxy]quinazolin-4-amine; N-(3-Chloro-4-fluoro-phenyl)-7-methoxy-6-(3-morpholin-4-ylpropoxy)quinazolin-4-amine; 4-(3'-Chloro-4'-fluoroanilino)-7-methoxy-6-(3-morpholinopropoxy)quinazoline; 6-(3-morpholinopropoxy)-N-(3-chloro-4-fluorophenyl)-7-methoxyquinazolin-4-amine Click to Show/Hide
Disease Class	2A00-2F9Z: Solid tumour/cancer; 2C93: Urethral cancer; 2D42: Head and neck cancer
Therapeutic Class	Antineoplastics
Structure
Structure	3D Structure		2D Structure
Formula	C22H24ClFN4O3
InChI	1S/C22H24ClFN4O3/c1-29-20-13-19-16(12-21(20)31-8-2-5-28-6-9-30-10-7-28)22(26-14-25-19)27-15-3-4-18(24)17(23)11-15/h3-4,11-14H,2,5-10H2,1H3,(H,25,26,27)
InChIKey	XGALLCVXEZPNRQ-UHFFFAOYSA-N
Canonical SMILES	COC1=C(C=C2C(=C1)N=CN=C2NC3=CC(=C(C=C3)F)Cl)OCCCN4CCOCC4
External Link
	Pubchem ID	123631
	CAS Number	184475-35-2
	CHEBI ID	49668
	TTD ID	D09XZB
	INTEDE ID	DR0764
	VARIDT ID	DR00423

Drug-Drug Interaction Network
Sunburst Graph		Legend Information AM001 Affected gastrointestinal absorption AM002 Affected cellular transport AM004 Affected intra/extra-hepatic metabolism AM006 Pharmacodynamic additive effects BM005 Altered gastric pH BM010 Transporter inhibition BM017 CYP450 enzyme inhibition BM022 CYP450 enzyme induction BM043 Additive immunosuppressive effects BM055 Increased risk of hepatotoxicity BM075 Increased risk of photosensitivity reactions
Relation Graph

Full list of drugs interacting with Gefitinib
Affected gastrointestinal absorption
	Altered gastric pH					Drug Num: 11
Drug ID		Drug Name	Formula	Pubchem ID	Severity Level		Interaction Detail	REF
D0337		Cimetidine	C10H16N6S	2756	Moderate		Inter Info	[40]
D0458		Dexlansoprazole	C16H14F3N3O2S	9578005	Moderate		Inter Info	[40]
D0603		Esomeprazole	C17H19N3O3S	9568614	Moderate		Inter Info	[40]
D0636		Famotidine	C8H15N7O2S3	5702160	Moderate		Inter Info	[40]
D0892		Lansoprazole	C16H14F3N3O2S	3883	Moderate		Inter Info	[40]
D1151		Nizatidine	C12H21N5O2S2	3033637	Moderate		Inter Info	[40]
D1179		Omeprazole	C17H19N3O3S	4594	Moderate		Inter Info	[40]
D1373		Rabeprazole	C18H21N3O3S	5029	Moderate		Inter Info	[40]
D1381		Ranitidine	C13H22N4O3S	3001055	Moderate		Inter Info	[40]
D1382		Ranitidine (bismuth citrate)	C13H22N4O3S	3001055	Moderate		Inter Info	[40]
D1222		Pantoprazole	C16H15F2N3O4S	4679	Moderate		Inter Info	[40]
Affected cellular transport
	Transporter inhibition					Drug Num: 6
Drug ID		Drug Name	Formula	Pubchem ID	Severity Level		Interaction Detail	REF
D1211		Ozanimod	C23H24N4O3	52938427	Major		Inter Info	[8], [9]
D0182		Binimetinib	C17H15BrF2N4O3	10288191	Moderate		Inter Info	[8], [27], [52]
D0963		Lusutrombopag	C29H32Cl2N2O5S	49843517	Moderate		Inter Info	[83]
D1407		Rimegepant	C28H28F2N6O3	51049968	Moderate		Inter Info	[96]
D1532		Talazoparib	C19H14F2N6O	135565082	Moderate		Inter Info	[98]
D1663		Ubrogepant	C29H26F3N5O3	68748835	Moderate		Inter Info	[106]
Affected intra/extra-hepatic metabolism
	CYP450 enzyme inhibition					Drug Num: 82
Drug ID		Drug Name	Formula	Pubchem ID	Severity Level		Interaction Detail	REF
D1574		Thioridazine	C21H26N2S2	5452	Major		Inter Info	[11], [12], [13], [14], [15], [16], [17], [18], [19], [20], [21], [22], [23]
D0119		Atomoxetine	C17H21NO	54841	Moderate		Inter Info	[36], [37], [38]
D0308		Cevimeline	C10H17NOS	83898	Moderate		Inter Info	[41]
D0367		Clotrimazole	C22H17ClN2	2812	Moderate		Inter Info	[39], [40]
D0402		Cyclosporine	C62H111N11O12	5284373	Moderate		Inter Info	[39], [40]
D0597		Erythromycin	C37H67NO13	12560	Moderate		Inter Info	[39], [40]
D0667		Fluconazole	C13H12F2N6O	3365	Moderate		Inter Info	[39], [40]
D0687		Fluvoxamine	C15H21F3N2O2	5324346	Moderate		Inter Info	[39], [40]
D0002		Abametapir (topical)	C12H12N2	15664	Moderate		Inter Info	[42]
D0066		Amiodarone	C25H29I2NO3	2157	Moderate		Inter Info	[39], [40]
D0080		Amprenavir	C25H35N3O6S	65016	Moderate		Inter Info	[39], [40]
D0100		Aprepitant	C23H21F7N4O3	135413536	Moderate		Inter Info	[44], [45], [46], [47], [48], [49]
D0105		Aripiprazole	C23H27Cl2N3O2	60795	Moderate		Inter Info	[50]
D0116		Atazanavir	C38H52N6O7	148192	Moderate		Inter Info	[39], [40]
D0171		Berotralstat	C30H26F4N6O	137528262	Moderate		Inter Info	[39], [40]
D0180		Bicalutamide	C18H14F4N2O4S	2375	Moderate		Inter Info	[39], [40]
D0192		Boceprevir	C27H45N5O5	10324367	Moderate		Inter Info	[39], [40]
D0302		Ceritinib	C28H36ClN5O3S	57379345	Moderate		Inter Info	[39], [40]
D0313		Chloramphenicol	C11H12Cl2N2O5	5959	Moderate		Inter Info	[39], [40]
D0341		Ciprofloxacin	C17H18FN3O3	2764	Moderate		Inter Info	[39], [40]
D0349		Clarithromycin	C38H69NO13	84029	Moderate		Inter Info	[39], [40]
D0375		Cobicistat	C40H53N7O5S2	25151504	Moderate		Inter Info	[39], [40]
D0379		Codeine	C18H21NO3	5284371	Moderate		Inter Info	[57], [58], [59], [60], [61], [62], [21], [63], [64], [65], [66], [67], [68]
D0386		Conivaptan	C32H26N4O2	151171	Moderate		Inter Info	[39], [40]
D0393		Crizotinib	C21H22Cl2FN5O	11626560	Moderate		Inter Info	[39], [40]
D0409		Dacomitinib	C24H25ClFN5O2	11511120	Moderate		Inter Info	[69]
D0413		Dalfopristin	C34H50N4O9S	6323289	Moderate		Inter Info	[39], [40]
D0416		Danazol	C22H27NO2	28417	Moderate		Inter Info	[39], [40]
D0424		Darifenacin	C28H30N2O2	444031	Moderate		Inter Info	[70], [37]
D0426		Darunavir	C27H37N3O7S	213039	Moderate		Inter Info	[39], [40]
D0428		Dasatinib	C22H26ClN7O2S	3062316	Moderate		Inter Info	[39], [40]
D0432		Deferasirox	C21H15N3O4	214348	Moderate		Inter Info	[71], [72]
D0439		Delavirdine	C22H28N6O3S	5625	Moderate		Inter Info	[39], [40]
D0497		Diltiazem	C22H26N2O4S	39186	Moderate		Inter Info	[39], [40]
D0534		Dronedarone	C31H44N2O5S	208898	Moderate		Inter Info	[39], [40]
D0539		Duloxetine	C18H19NOS	60835	Moderate		Inter Info	[73], [74]
D0543		Duvelisib	C22H17ClN6O	50905713	Moderate		Inter Info	[39], [40]
D0577		Entrectinib	C31H34F2N6O2	25141092	Moderate		Inter Info	[39], [40]
D0638		Fedratinib	C27H36N6O3S	16722836	Moderate		Inter Info	[39], [40]
D0655		Fesoterodine	C26H37NO3	6918558	Moderate		Inter Info	[77]
D0692		Fosamprenavir	C25H36N3O9PS	131536	Moderate		Inter Info	[39], [40]
D0696		Fosnetupitant	C31H35F6N4O5P	71544786	Moderate		Inter Info	[39], [40]
D0699		Fostamatinib	C23H26FN6O9P	11671467	Moderate		Inter Info	[78]
D0724		Givosiran	C78H139N11O30	119058042	Moderate		Inter Info	[79]
D0793		Imatinib	C29H31N7O	5291	Moderate		Inter Info	[39], [40]
D0852		Isavuconazonium	C35H35F2N8O5S+	6918606	Moderate		Inter Info	[39], [40]
D0858		Isoniazid	C6H7N3O	3767	Moderate		Inter Info	[39], [40]
D0867		Itraconazole	C35H38Cl2N8O4	55283	Moderate		Inter Info	[39], [40]
D0869		Ivacaftor	C24H28N2O3	16220172	Moderate		Inter Info	[39], [40]
D0880		Ketoconazole	C26H28Cl2N4O4	456201	Moderate		Inter Info	[39], [40]
D0894		Lapatinib	C29H26ClFN4O4S	208908	Moderate		Inter Info	[39], [40]
D0896		Larotrectinib	C21H22F2N6O2	46188928	Moderate		Inter Info	[39], [40]
D0899		Lefamulin	C28H45NO5S	25185057	Moderate		Inter Info	[81]
D0906		Letermovir	C29H28F4N4O4	45138674	Moderate		Inter Info	[39], [40]
D0946		Lonafarnib	C27H31Br2ClN4O2	148195	Moderate		Inter Info	[39], [40]
D1057		Miconazole	C18H14Cl4N2O	4189	Moderate		Inter Info	[39], [40]
D1063		Mifepristone	C29H35NO2	55245	Moderate		Inter Info	[8], [27], [85], [86]
D1117		Nefazodone	C25H32ClN5O2	4449	Moderate		Inter Info	[39], [40]
D1127		Netupitant	C30H32F6N4O	6451149	Moderate		Inter Info	[39], [40]
D1134		Nifedipine	C17H18N2O6	4485	Moderate		Inter Info	[39], [40]
D1136		Nilotinib	C28H22F3N7O	644241	Moderate		Inter Info	[39], [40]
D1189		Osilodrostat	C13H10FN3	44139752	Moderate		Inter Info	[39], [40]
D1315		Posaconazole	C37H42F2N8O4	468595	Moderate		Inter Info	[39], [40]
D1398		Ribociclib	C23H30N8O	44631912	Moderate		Inter Info	[39], [40]
D1408		Riociguat	C20H19FN8O2	11304743	Moderate		Inter Info	[3], [8], [27], [97]
D1415		Ritonavir	C37H48N6O5S2	392622	Moderate		Inter Info	[39], [40]
D1432		Rucaparib	C19H18FN3O	9931954	Moderate		Inter Info	[39], [40]
D1444		Saquinavir	C38H50N6O5	441243	Moderate		Inter Info	[39], [40]
D1459		Selpercatinib	C29H31N7O3	134436906	Moderate		Inter Info	[39], [40]
D1541		Telaprevir	C36H53N7O6	3010818	Moderate		Inter Info	[39], [40]
D1544		Telithromycin	C43H65N5O10	3002190	Moderate		Inter Info	[39], [40]
D1586		Timolol (ophthalmic)	C13H24N4O3S	33624	Moderate		Inter Info	[100], [101], [102]
D1660		Tucatinib	C26H24N8O2	51039094	Moderate		Inter Info	[39], [40]
D1690		Verapamil	C27H38N2O4	2520	Moderate		Inter Info	[39], [40]
D1706		Voriconazole	C16H14F3N5O	71616	Moderate		Inter Info	[39], [40]
D1709		Voxelotor	C19H19N3O3	71602803	Moderate		Inter Info	[39], [40]
D1714		Zafirlukast	C31H33N3O6S	5717	Moderate		Inter Info	[39], [40]
D0799		Indinavir	C36H47N5O4	5362440	Moderate		Inter Info	[39], [40]
D1119		Nelfinavir	C32H45N3O4S	64143	Moderate		Inter Info	[39], [40]
D0516		Donepezil	C24H29NO3	3152	Minor		Inter Info	[114], [21], [115], [116]
D1607		Tolterodine	C22H31NO	443879	Minor		Inter Info	[117], [118], [21]
D1383		Ranolazine	C24H33N3O4	56959	Minor		Inter Info	[119]
	CYP450 enzyme induction					Drug Num: 47
Drug ID		Drug Name	Formula	Pubchem ID	Severity Level		Interaction Detail	REF
D0178		Bexarotene	C24H28O2	82146	Moderate		Inter Info	[39], [40]
D0224		Butabarbital	C10H16N2O3	2479	Moderate		Inter Info	[39], [40]
D0225		Butalbital	C11H16N2O3	2481	Moderate		Inter Info	[39], [40]
D0061		Aminoglutethimide	C13H16N2O2	2145	Moderate		Inter Info	[39], [40]
D0071		Amobarbital	C11H18N2O3	2164	Moderate		Inter Info	[39], [40]
D0095		Apalutamide	C21H15F4N5O2S	24872560	Moderate		Inter Info	[39], [40]
D0194		Bosentan	C27H29N5O6S	104865	Moderate		Inter Info	[39], [40]
D0204		Brigatinib	C29H39ClN7O2P	68165256	Moderate		Inter Info	[54]
D0255		Carbamazepine	C15H12N2O	2554	Moderate		Inter Info	[39], [40]
D0300		Cenobamate	C10H10ClN5O2	11962412	Moderate		Inter Info	[39], [40]
D0406		Dabrafenib	C23H20F3N5O2S2	44462760	Moderate		Inter Info	[39], [40]
D0453		Dexamethasone	C22H29FO5	5743	Moderate		Inter Info	[39], [40]
D0545		Echinacea	NA	NA	Moderate		Inter Info	[8], [75]
D0554		Efavirenz	C14H9ClF3NO2	64139	Moderate		Inter Info	[39], [40]
D0555		Elagolix	C32H30F5N3O5	11250647	Moderate		Inter Info	[39], [40]
D0578		Enzalutamide	C21H16F4N4O2S	15951529	Moderate		Inter Info	[39], [40]
D0628		Etravirine	C20H15BrN6O	193962	Moderate		Inter Info	[39], [40]
D0639		Felbamate	C11H14N2O4	3331	Moderate		Inter Info	[39], [40]
D0697		Fosphenytoin	C16H15N2O6P	56339	Moderate		Inter Info	[39], [40]
D0741		Griseofulvin	C17H17ClO6	441140	Moderate		Inter Info	[39], [40]
D0872		Ivosidenib	C28H22ClF3N6O3	71657455	Moderate		Inter Info	[39], [40]
D0901		Lemborexant	C22H20F2N4O2	56944144	Moderate		Inter Info	[39], [82], [40]
D0953		Lorlatinib	C21H19FN6O2	71731823	Moderate		Inter Info	[39], [40]
D1040		Methylphenobarbital	C13H14N2O3	8271	Moderate		Inter Info	[39], [82], [40]
D1078		Mitotane	C14H10Cl4	4211	Moderate		Inter Info	[39], [40]
D1099		Nafcillin	C21H22N2O5S	8982	Moderate		Inter Info	[39], [40]
D1198		Oxcarbazepine	C15H12N2O2	34312	Moderate		Inter Info	[39], [40]
D1265		Phenobarbital	C12H12N2O3	4763	Moderate		Inter Info	[39], [40]
D1274		Phenylbutazone	C19H20N2O2	4781	Moderate		Inter Info	[39], [40]
D1340		Primidone	C12H14N2O2	4909	Moderate		Inter Info	[39], [40]
D1399		Rifabutin	C46H62N4O11	135398743	Moderate		Inter Info	[39], [40]
D1400		Rifampicin	C43H58N4O12	135398735	Moderate		Inter Info	[39], [82], [40]
D1401		Rifapentine	C47H64N4O12	135403821	Moderate		Inter Info	[39], [40]
D1493		Somapacitan	C54H95N13O20S2	129894493	Moderate		Inter Info	[39], [82], [40]
D1495		Somatrem	C43H72N14O14	5487805	Moderate		Inter Info	[39], [40]
D1502		St. John's Wort	NA	NA	Moderate		Inter Info	[39], [40]
D1518		Sulfinpyrazone	C23H20N2O3S	5342	Moderate		Inter Info	[39], [40]
D1538		Tazemetostat	C34H44N4O4	66558664	Moderate		Inter Info	[39], [40]
D1546		Telotristat ethyl	C27H26ClF3N6O3	25181577	Moderate		Inter Info	[27], [99]
D1687		Vemurafenib	C23H18ClF2N3O3S	42611257	Moderate		Inter Info	[39], [40]
D1128		Nevirapine	C15H14N4O	4463	Moderate		Inter Info	[39], [40]
D1248		Pentobarbital	C11H18N2O3	4737	Moderate		Inter Info	[39], [40]
D1283		Phenytoin	C15H12N2O2	1775	Moderate		Inter Info	[39], [40]
D1494		Somatotropin	NA	NA	Moderate		Inter Info	[39], [82], [40]
D1652		Troglitazone	C24H27NO5S	5591	Moderate		Inter Info	[39], [40]
D0106		Armodafinil	C15H15NO2S	9690109	Minor		Inter Info	[109], [110], [111], [112], [113]
D1081		Modafinil	C15H15NO2S	4236	Minor		Inter Info	[109], [110], [111], [112], [113]
Pharmacodynamic additive effects
	Additive immunosuppressive effects					Drug Num: 1
Drug ID		Drug Name	Formula	Pubchem ID	Severity Level		Interaction Detail	REF
D1174		Omacetaxine mepesuccinate	C29H39NO9	285033	Moderate		Inter Info	[88]
	Increased risk of hepatotoxicity					Drug Num: 23
Drug ID		Drug Name	Formula	Pubchem ID	Severity Level		Interaction Detail	REF
D0900		Leflunomide	C12H9F3N2O2	3899	Major		Inter Info	[3], [4], [5]
D0944		Lomitapide	C39H37F6N3O2	9853053	Major		Inter Info	[6]
D1073		Mipomersen	C230H324N67O122P19S19	118984467	Major		Inter Info	[7]
D1258		Pexidartinib	C20H15ClF3N5	25151352	Major		Inter Info	[10]
D1556		Teriflunomide	C12H9F3N2O2	54684141	Major		Inter Info	[3], [4], [5]
D0114		Asparaginase Escherichia coli	NA	NA	Moderate		Inter Info	[24], [25], [26], [8], [27], [28], [29], [30], [31], [32], [33], [34], [35]
D0113		Asparaginase Erwinia chrysanthemi	NA	NA	Moderate		Inter Info	[24], [25], [26], [8], [27], [28], [29], [30], [31], [32], [33], [34], [35]
D0149		Bedaquiline	C32H31BrN2O2	5388906	Moderate		Inter Info	[51]
D0199		Brentuximab vedotin	NA	NA	Moderate		Inter Info	[53]
D0232		Calaspargase pegol	NA	NA	Moderate		Inter Info	[24], [25], [26], [8], [27], [28], [29], [30], [31], [32], [33], [34], [35]
D0248		Cannabidiol	C21H30O2	644019	Moderate		Inter Info	[27], [55]
D0357		Clofarabine	C10H11ClFN5O3	119182	Moderate		Inter Info	[56]
D0584		Epirubicin	C27H29NO11	41867	Moderate		Inter Info	[8], [27], [76]
D0789		Idelalisib	C22H18FN7O	11625818	Moderate		Inter Info	[80]
D1025		Methotrexate	C20H22N8O5	126941	Moderate		Inter Info	[27], [84]
D1106		Naltrexone	C20H23NO4	5360515	Moderate		Inter Info	[87]
D1239		Peginterferon beta-1a	NA	NA	Moderate		Inter Info	[89], [90], [91], [92]
D1389		Remdesivir	C27H35N6O8P	121304016	Moderate		Inter Info	[8], [27], [93], [94], [95]
D1589		Tioguanine	C5H5N5S	2723601	Moderate		Inter Info	[103], [104]
D1615		Trabectedin	C39H43N3O11S	108150	Moderate		Inter Info	[27], [105]
D0826		Interferon beta-1a	NA	NA	Moderate		Inter Info	[89], [90], [91], [92]
D0827		Interferon beta-1b	NA	NA	Moderate		Inter Info	[89], [90], [91], [92]
D1234		Pegaspargase	C14H19NO	436058	Moderate		Inter Info	[24], [25], [26], [8], [27], [28], [29], [30], [31], [32], [33], [34], [35]
	Increased risk of photosensitivity reactions					Drug Num: 4
Drug ID		Drug Name	Formula	Pubchem ID	Severity Level		Interaction Detail	REF
D0062		Aminolevulinic acid	C5H9NO3	137	Major		Inter Info	[1], [2]
D0063		Aminolevulinic acid (topical)	C5H9NO3	137	Moderate		Inter Info	[8], [27], [43]
D1033		Methyl aminolevulinate (topical)	C6H11NO3	157922	Moderate		Inter Info	[8], [27], [43]
D1691		Verteporfin	C82H84N8O16	11980904	Moderate		Inter Info	[27], [107], [1], [108]

References
1	Product Information. Nulibry (fosdenopterin). Origin Biosciences Inc, Boston, MA.
2	Product Information. Gleolan (aminolevulinic acid). NX Development Corp, Lexington, KY.
3	Canadian Pharmacists Association.
4	EMEA "EMEA public statement on leflunomide (ARAVA) - severe and serious hepatic reactions.".
5	Product Information. Arava (leflunomide). Hoechst Marion-Roussel Inc, Kansas City, MO.
6	Product Information. Juxtapid (lomitapide). Aegerion Pharmaceuticals Inc, Cambridge, MA.
7	Product Information. Kynamro (mipomersen). Genzyme Corporation, Cambridge, MA.
8	Cerner Multum, Inc. "Australian Product Information.".
9	Product Information. Zeposia (ozanimod). Celgene Corporation, Summit, NJ.
10	Product Information. Turalio (pexidartinib). Daiichi Sankyo, Inc., Parsippany, NJ.
11	Abernethy DR, Greenblatt DJ, Steel K, Shader RI "Impairment of hepatic drug oxidation by propoxyphene." Ann Intern Med 97 (1982): 223-4. [PMID: 7103282]
12	Carrillo JA, Ramos SI, Herraiz AG, Llerena A, Agundez JAG, Berecz R, Duran M, Benitez J "Pharmacokinetic interaction of fluvoxamine and thioridazine in schizophrenic patients." J Clin Psychopharmacol 19 (1999): 494-9. [PMID: 10587283]
13	Fletcher GF, Kazamias TM "Cardiotoxic effects of Mellaril: conduction disturbances and supraventricular arrhythmias." Am Heart J 78 (1969): 135-8. [PMID: 5794785]
14	Glassman AH, Bigger JT Jr "Antipsychotic drugs: prolonged QTc interval, torsade de pointes, and sudden death." Am J Psychiatry 158 (2001): 1774-82. [PMID: 11691681]
15	Greendyke RM, Gulya A "Effect of pindolol administration on serum levels of thioridazine, haloperidol, phenytoin, and phenobarbital." J Clin Psychiatry 49 (1988): 105-7. [PMID: 3346197]
16	Greendyke RM, Kanter DR "Plasma propranolol levels and their effect on plasma thioridazine and haloperidol concentrations." J Clin Psychopharmacol 7 (1987): 178-82. [PMID: 3597804]
17	Hartigan-Go K, Bateman DN, Nyberg G, Martensson E, Thomas SHL "Concentration-related pharmacodynamic effects of thioridazine and its metabolites in humans." Clin Pharmacol Ther 60 (1996): 543-53. [PMID: 8941027]
18	Markowitz JS, Wells BG, Carson WH "Interactions between antipsychotic and antihypertensive drugs." Ann Pharmacother 29 (1995): 603-9. [PMID: 7663034]
19	Product Information. Mellaril (thioridazine). Sandoz Pharmaceuticals Corporation, East Hanover, NJ.
20	Product Information. Prozac (fluoxetine). Dista Products Company, Indianapolis, IN.
21	Product Information. Varubi (rolapitant). Tesaro Inc., Waltham, MA.
22	Silver JM, Yudofsky SC, Kogan M, Katz BL "Elevation of thioridazine plasma levels by propranolol." Am J Psychiatry 143 (1986): 1290-2. [PMID: 3766793]
23	Thomas M, Maconochie JG, Fletcher E "The dilemma of the prolonged QT interval in early drug studies." Br J Clin Pharmacol 41 (1996): 77-81. [PMID: 8838432]
24	Al-Nawakil C, Willems L, Mauprivez C, et.al "Successful treatment of l-asparaginase-induced severe acute hepatotoxicity using mitochondrial cofactors." Leuk Lymphoma 55 (2014): 1670-4. [PMID: 24090500]
25	Bodmer M, Sulz M, Stadlmann S, Droll A, Terracciano L, Krahenbuhl S "Fatal liver failure in an adult patient with acute lymphoblastic leukemia following treatment with L-asparaginase." Digestion 74 (2006): epub. [PMID: 16988508]
26	Cerner Multum, Inc "ANVISA Bulario Eletrnico.".
27	Cerner Multum, Inc. "UK Summary of Product Characteristics.".
28	Christ TN, Stock W, Knoebel RW "Incidence of asparaginase-related hepatotoxicity, pancreatitis, and thrombotic events in adults with acute lymphoblastic leukemia treated with a pediatric-inspired regimen." J Oncol Pharm Pract 24 (2018): 299-308. [PMID: 28355969]
29	Jenkins R, Perlin E "Severe hepatotoxicity from Escherichia coli L-asparaginase." J Natl Med Assoc 79 (1987): 775-9. [PMID: 3305969]
30	Lu G, Karur V, Herrington JD, Walker MG "Successful treatment of pegaspargase-induced acute hepatotoxicity with vitamin B complex and L-carnitine" Proc (Bayl Univ Med Cent) 29 (2016): 46-7. [PMID: 26722167]
31	Product Information. Asparlas (calaspargase pegol). Servier, Boston, MA.
32	Product Information. Elspar (asparaginase). Merck & Co, Inc, West Point, PA.
33	Product Information. Erwinaze (asparaginase Erwinia chrysanthemi). EUSA Pharma, Newtown, PA.
34	Product Information. Oncaspar (pegaspargase). Rhone-Poulenc Rorer, Collegeville, PA.
35	Burke PW, Aldoss I, Lunning MA, et.al "High-grade PEGylated asparaginase-related hepatotoxicity occurrence in a pediatric-inspired adult acute lymphoblastic leukemia regimen does not necessarily predict recurrent hepatotoxicity in subsequent cycles." Blood 122 (2013): 2671. [PMID: 29407583]
36	Belle DJ, Ernest CS, Sauer JM, Smith BP, Thomasson HR, Witcher JW "Effect of potent CYP2D6 inhibition by paroxetine on atomoxetine pharmacokinetics." J Clin Pharmacol 42 (2002): 1219-27. [PMID: 12412820]
37	Product Information. Qelbree (viloxazine). Supernus Pharmaceuticals Inc, Rockville, MD.
38	Product Information. Strattera (atomoxetine). Lilly, Eli and Company, Indianapolis, IN.
39	Li J, Zhao M, He P, Hidalgo M, Baker SD "Differential metabolism of gefitinib and erlotinib by human cytochrome p450 enzymes." Clin Cancer Res 13 (2007): 3731-7. [PMID: 17575239]
40	Product Information. Iressa (gefitinib). Astra-Zeneca Pharmaceuticals, Wilmington, DE.
41	Product Information. Evoxac (cevimeline) Daiichi Pharmaceuticals, Fort lee, NJ.
42	Product Information. Xeglyze (abametapir topical). Dr. Reddy's Laboratories Inc, Upper Saddle River, NJ.
43	Product Information. Metvixia (methyl aminolevulinate topical). Galderma Laboratories Inc, Cranbury, NJ.
44	Charasson V, Haaz MC, Robert J "Determination of Drug Interactions Occurring with the Metabolic Pathways of Irinotecan." Drug Metab Dispos 30 (2002): 731-733. [PMID: 12019202]
45	Clarke SJ, Rivory LP "Clinical pharmacokinetics of docetaxel." Clin Pharmacokinet 36 (1999): 99-114. [PMID: 10092957]
46	Kivisto KT, Kroemer HK, Eichelbaum M "The role of human cytochrome p450 enzymes in the metabolism of anticancer agents: implications for drug interactions." Br J Clin Pharmacol 40 (1995): 523-30. [PMID: 8703657]
47	Product Information. Emend (aprepitant). Merck & Company Inc, West Point, PA.
48	Product Information. Emend for Injection (fosaprepitant). Merck & Company Inc, West Point, PA.
49	Zhou XJ, Zhou-Pan XR, Gauthier T, Placidi M, Maurel P, Rahmani R "Human liver microsomal cytochrome P450 3A isozymes mediated vindesine biotransformation. Metabolic drug interactions." Biochem Pharmacol 45 (1993): 853-61. [PMID: 8452560]
50	Product Information. Abilify (aripiprazole). Bristol-Myers Squibb, Princeton, NJ.
51	Product Information. Sirturo (bedaquiline). Janssen Pharmaceuticals, Titusville, NJ.
52	Product Information. Mektovi (binimetinib). Array BioPharma Inc., Boulder, CO.
53	Product Information. Adcetris (brentuximab vedotin). Seattle Genetics Inc, Bothell, WA.
54	Product Information. Alunbrig (brigatinib). Ariad Pharmaceuticals Inc, Cambridge, MA.
55	Product Information. Epidiolex (cannabidiol). Greenwich Biosciences Inc, Carlsbad, CA.
56	Product Information. Clolar (clofarabine). sanofi-aventis, Bridgewater, NJ.
57	Caraco Y, Sheller J, Wood AJJ "Impact of ethnic origin and quinidine coadministration on codeine's disposition and pharmacodynamic effects." J Pharmacol Exp Ther 290 (1999): 413-22. [PMID: 10381807]
58	Caraco Y, Sheller J, Wood JJ "Pharmacogenetic determination of the effects of codeine and prediction of drug interactions." J Pharmacol Exp Ther 278 (1996): 1165-74. [PMID: 8819499]
59	Desmeules J, Dayer P, Gascon MP, Magistris M "Impact of genetic and environmental factors on codeine analgesia." Clin Pharmacol Ther 45 (1989): 122. [PMID: 1782973]
60	Desmeules J, Gascon MP, Dayer P, Magistris M "Impact of environmental and genetic factors on codeine analgesia." Eur J Clin Pharmacol 41 (1991): 23-6. [PMID: 1782973]
61	Hersh EV, Moore PA "Drug interactions in dentistry: the importance of knowing your CYPs." J Am Dent Assoc 135 (2004): 298-311. [PMID: 15058617]
62	Poulsen L, Brosen K, Srendt-Nielsen L, Gram LF, Elbaek K, Sindrup SH "Codeine and morphine in extensive and poor metabolizers of sparteine: pharmacokinetics, analgesic effect and side effects." Eur J Clin Pharmacol 51 (1996): 289-95. [PMID: 9010701]
63	Sindrup SH, Arendt-Nielsen L, Brosen K, et al "The effect of quinidine on the analgesic effect of codeine." Eur J Clin Pharmacol 42 (1992): 587-92. [PMID: 1623898]
64	Sindrup SH, Brosen K, Bjerring P, et al. "Codeine increases pain threshold to copper vapor laser stimuli in extensive but not poor metabolizers of sparteine." Clin Pharmacol Ther 49 (1991): 686-93. [PMID: 2249379]
65	Sindrup SH, Hofmann U, Asmussen J, Mikus G, Brosen K, Nielsen F, Ingwersen SH, Broen Christensen C "Impact of quinidine on plasma and cerebrospinal fluid concentrations of codeine and morphine after codeine intake." Eur J Clin Pharmacol 49 (1996): 503-9. [PMID: 8706777]
66	Thorn CF, Klein TE, Altman RB "Codeine and morphine pathway." Pharmacogenet Genomics 19 (2009): 556-8. [PMID: 19512957]
67	Vevelstad M, Pettersen S, Tallaksen C, Brors O "O-demethylation of codeine to morphine inhibited by low-dose levomepromazine." Eur J Clin Pharmacol 65 (2009): 795-801. [PMID: 19308365]
68	Zhou SF "Polymorphism of human cytochrome P450 2D6 and its clinical significance: part II." Clin Pharmacokinet 48 (2009): 761-804. [PMID: 19902987]
69	Product Information. Vizimpro (dacomitinib). Pfizer U.S. Pharmaceuticals Group, New York, NY.
70	Product Information. Enablex (darifenacin). Novartis Pharmaceuticals, East Hanover, NJ.
71	Product Information. Exjade (deferasirox). Novartis Pharmaceuticals, East Hanover, NJ.
72	Skerjanec A, Wang J, Maren K, Rojkjaer L "Investigation of the pharmacokinetic interactions of deferasirox, a once-daily oral iron chelator, with midazolam, rifampin, and repaglinide in healthy volunteers." J Clin Pharmacol 50 (2010): 205-13. [PMID: 19940232]
73	Product Information. Cymbalta (duloxetine). Lilly, Eli and Company, Indianapolis, IN.
74	Skinner MH, Kuan HY, Pan A, et al. "Duloxetine is both an inhibitor and a substrate of cytochrome P4502D6 in healthy volunteers." Clin Pharmacol Ther 73 (2003): 170-7. [PMID: 12621382]
75	Gorski JC, Huang SM, Pinto A, et al. "The effect of echinacea (Echinacea purpurea root) on cytochrome P450 activity in vivo." Clin Pharmacol Ther 75 (2004): 89-100. [PMID: 14749695]
76	Product Information. Ellence (epirubicin) Pharmacia and Upjohn, Kalamazoo, MI.
77	Product Information. Toviaz (fesoterodine). Pfizer U.S. Pharmaceuticals Group, New York, NY.
78	Product Information. Tavalisse (fostamatinib). Rigel Pharmaceuticals, South San Francisco, CA.
79	Product Information. Givlaari (givosiran). Alnylam Pharmaceuticals, Cambridge, MA.
80	Product Information. Zydelig (idelalisib). Gilead Sciences, Foster City, CA.
81	Product Information. Xenleta (lefamulin). Nabriva Therapeutics US, Inc., King of Prussia, PA.
82	Product Information. Diabinese (chlorpropamide). Pfizer US Pharmaceuticals, New York, NY.
83	EMA. European Medicines Agency. European Union "EMA - List of medicines under additional monitoring.".
84	Product Information. Methotrexate (methotrexate). Lederle Laboratories, Wayne, NJ.
85	He K, Woolf TF, Hollenberg PF "Mechanism-based inactivation of cytochrome P-450-3A4 by mifepristone (RU486)." J Pharmacol Exp Ther 288 (1999): 791-7. [PMID: 9918590]
86	Product Information. Mifeprex (mifepristone) Danco Laboratories, New York, NY.
87	Product Information. ReVia (naltrexone). DuPont Pharmaceuticals, Wilmington, DE.
88	Product Information. Synribo (omacetaxine). Teva Pharmaceuticals USA, North Wales, PA.
89	Product Information. Avonex (interferon beta-1a). Biogen, Cambridge, MA.
90	Product Information. Betaseron (interferon beta-1b). Berlex, Richmond, CA.
91	Product Information. Plegridy (peginterferon beta-1a). Biogen Idec Inc, Cambridge, MA.
92	Product Information. Rebif (interferon beta-1a). Serono Laboratories Inc, Norwell, MA.
93	European Medicines Agency "Summary on compassionate use. Remdesivir Gilead.".
94	Gilead Sciences, Inc "About Remdesivir.".
95	US Food and Drug Administration "Fact sheet for health care providers emergency use authorization (EUA) of remdesivir (GS-5734TM)".
96	Product Information. Nurtec ODT (rimegepant). Biohaven Pharmaceuticals, New Haven, CT.
97	Product Information. Ziagen (abacavir). Glaxo Wellcome, Research Triangle Pk, NC.
98	Product Information. Talzenna (talazoparib). Pfizer U.S. Pharmaceuticals Group, New York, NY.
99	Product Information. Xermelo (telotristat ethyl). Lexicon Pharmaceuticals, Inc., The Woodlands, TX.
100	Edeki TI, He HB, Wood AJJ "Pharmacogenetic explanation for excessive beta-blockade following timolol eye drops: potential for oral-ophthalmic drug interaction." JAMA 274 (1995): 1611-3. [PMID: 7474246]
101	Fraunfelder FT, Fraunfelder FW Randall JA "Drug-Induced Ocular Side Effects 5th" Boston, MA: Butterworth-Heinemann (2001):.
102	Lewis RV, Lennard MS, Jackson PR, Tucker GT, Ramsay LE, Woods HF "Timolol and atenolol: relationships between oxidation phenotype, pharmacokinetics and pharmacodynamics." Br J Clin Pharmacol 19 (1985): 329-33. [PMID: 2859048]
103	Product Information. Aubagio (teriflunomide). Genzyme Corporation, Cambridge, MA.
104	Product Information. Tabloid (thioguanine). Prasco Laboratories, Cincinnati, OH.
105	Product Information. Yondelis (trabectedin). Janssen Pharmaceuticals, Titusville, NJ.
106	Product Information. Ubrelvy (ubrogepant). Allergan Inc, Irvine, CA.
107	Multum Information Services, Inc. Expert Review Panel.
108	Product Information. Visudyne (verteporfin) Valeant Pharmaceuticals, Costa Mesa, CA.
109	Doherty MM, Charman WN "The mucosa of the small intestine: how clinically relevant as an organ of drug metabolism?" Clin Pharmacokinet 41 (2002): 235-53. [PMID: 11978143]
110	Product Information. Nuvigil (armodafinil). Cephalon Inc, West Chester, PA.
111	Product Information. Provigil (modafinil). Cephalon, Inc, West Chester, PA.
112	Robertson P Jr, Hellriegel ET, Arora S, Nelson M "Effect of modafinil on the pharmacokinetics of ethinyl estradiol and triazolam in healthy volunteers." Clin Pharmacol Ther 71 (2002): 46-56. [PMID: 11823757]
113	Robertson P, Decory HH, Madan A, Parkinson A "In vitro inhibition and induction of human hepatic cytochrome P450 enzymes by modafinil." Drug Metab Dispos 28 (2000): 664-71. [PMID: 10820139]
114	Product Information. Aricept (donepezil). Pfizer US Pharmaceuticals, New York, NY.
115	Rojas-Fernandez C, Fisher C "Drug interactions and donepezil." J Am Geriat Soc 40 (2000): 597-8. [PMID: 10811561]
116	Tiseo PJ, Perdomo CA, Friedhoff LT "Concurrent administration of donepezil HCl and ketoconazole: assessment of pharmacokinetic changes following single and multiple doses." Br J Clin Pharmacol 46 (1998): 30-4. [PMID: 9839763]
117	Brynne N, Svanstrom C, AbergWistedt A, Hallen B, Bertilsson L "Fluoxetine inhibits the metabolism of tolterodin-pharmacokinetic implications and proposed clinical relevance." Br J Clin Pharmacol 48 (1999): 553-63. [PMID: 10583026]
118	Product Information. Detrol (tolterodine). Pharmacia and Upjohn, Kalamazoo, MI.
119	Product Information. Ranexa (ranolazine). Calmoseptine Inc, Huntington Beach, CA.

Details of Drug

Details of Drug

Cite MecDDI

About MecDDI

Correspondence